Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Alberto Cascón, Mercedes Robledo and colleagues show that MAX germline mutations confer susceptibility to hereditary pheochromocytoma. This finding supports a key role for MAX and its interaction partners in tumors of neural crest cell origin. Hereditary pheochromocytoma (PCC) is often caused by ger...
Saved in:
Published in | Nature genetics Vol. 43; no. 7; pp. 663 - 667 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.07.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1061-4036 1546-1718 1546-1718 |
DOI | 10.1038/ng.861 |
Cover
Summary: | Alberto Cascón, Mercedes Robledo and colleagues show that
MAX
germline mutations confer susceptibility to hereditary pheochromocytoma. This finding supports a key role for MAX and its interaction partners in tumors of neural crest cell origin.
Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date
1
,
2
,
3
,
4
, but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in
MAX
, the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of
MAX
alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional
MAX
mutations and suggested an association with malignant outcome and preferential paternal transmission of
MAX
mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells
5
and by the amplification of
MYCN
in neuroblastoma
6
and suggests that loss of MAX function is correlated with metastatic potential. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/ng.861 |